ArticleLeukemia2008

Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia.

T Matsunaga et al.PubMed ↗Publisher ↗

No numbers read from the abstract.